NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 122 filers reported holding NEKTAR THERAPEUTICS in Q1 2024. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $868 | +32.7% | 700 | 0.0% | 0.00% | – |
| Q1 2024 | $654 | +65.2% | 700 | 0.0% | 0.00% | – |
| Q4 2023 | $396 | -55.7% | 700 | -53.3% | 0.00% | -100.0% |
| Q3 2023 | $893 | +3.5% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $863 | +86200.0% | 1,500 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1 | -66.7% | 1,500 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $3 | -100.0% | 1,500 | -25.0% | 0.00% | -60.0% |
| Q3 2022 | $6,000 | -25.0% | 2,000 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $8,000 | -42.9% | 2,000 | +100.0% | 0.01% | -33.3% |
| Q1 2022 | $14,000 | 0.0% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $14,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |